Begoña Bermejo Fraile-rekin lankidetzan egindako argitalpenak (48)

2023

  1. Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies

    Cancers, Vol. 15, Núm. 18

  2. Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy

    ACS Applied Materials and Interfaces, Vol. 15, Núm. 32, pp. 38323-38334

  3. Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  4. High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer

    International journal of molecular sciences, Vol. 24, Núm. 4

  5. miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer

    Cancers, Vol. 15, Núm. 7

2022

  1. Immunological Landscape of HER-2 Positive Breast Cancer

    Cancers, Vol. 14, Núm. 13

  2. Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer

    Science Advances, Vol. 8, Núm. 20

  3. miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies

    Cancer Communications

2021

  1. Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer

    ESMO Open, Vol. 6, Núm. 1

  2. Fertility and breast cancer: A literature review of counseling, preservation options and outcomes

    Critical Reviews in Oncology/Hematology, Vol. 166

  3. Identification of a two-microrna signature in plasma as a novel biomarker for very early diagnosis of breast cancer

    Cancers, Vol. 13, Núm. 11

  4. Nanoporous Anodic Alumina-Based Sensor for miR-99a-5p Detection as an Effective Early Breast Cancer Diagnostic Tool

    ACS Sensors, Vol. 6, Núm. 3, pp. 1022-1029

  5. Oral selective estrogen receptor degraders (Serds) as a novel breast cancer therapy: Present and future from a clinical perspective

    International Journal of Molecular Sciences, Vol. 22, Núm. 15

2020

  1. Association between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women with Breast Cancer

    JAMA Dermatology, Vol. 156, Núm. 9, pp. 987-991

  2. Circulating mir-99a-5p expression in plasma: A potential biomarker for early diagnosis of breast cancer

    International Journal of Molecular Sciences, Vol. 21, Núm. 19, pp. 1-14

  3. Combination of phenotype and polygenic risk score in breast cancer risk evaluation in the Spanish population: a case –control study

    BMC Cancer, Vol. 20, Núm. 1

  4. HDAC5 inhibitors as a potential treatment in breast cancer affecting very young women

    Cancers, Vol. 12, Núm. 2

  5. MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma

    Frontiers in Oncology, Vol. 10

2019

  1. Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic Indicator

    Breast Cancer: Basic and Clinical Research, Vol. 13

  2. Detection of TP53 and PIK3CA mutations in circulating tumor DNA using next-generation sequencing in the screening process for early breast cancer diagnosis

    Journal of Clinical Medicine, Vol. 8, Núm. 8